Litcius/Paper detail

Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy

Kirsten A. White, Kate Connor, Maxime Meylan, Antoine Bougoüin, Manuela Salvucci, Franck Bielle, Alice C. O’Farrell, Kieron J. Sweeney, Lihong Weng, Gabriele Bergers, Patrick Dicker, David M. Ashley, Eric Lipp, Justin Low, Junfei Zhao, Pengbo Wen, Robert M. Prins, Maïté Verreault, Ahmed Idbaïh, Antara Biswas, Jochen H.M. Prehn, Diether Lambrechts, Ingrid Arijs, Francesca Lodi, Gonca Dilcan, Martine L.M. Lamfers, Sieger Leenstra, Federica Fabro, Ioannis Ntafoulis, Johan M. Kros, Jane Cryan, Francesca M. Brett, Emie Quissac, Alan Beausang, Steve MacNally, Philip J. O’Halloran, James Clerkin, Orna Bacon, Andreas Kremer, Romain Tching Chi Yen, Frederick S. Varn, Roel G.W. Verhaak, Catherine Sautès‐Fridman, Wolf H. Fridman, Annette T. Byrne

2022Annals of Oncology125 citationsDOIOpen Access PDF

Topics & Concepts

ImmunotherapyMedicineTumor microenvironmentImmune systemGliomaImmune checkpointCancer researchPopulationImmunologyOncologyEnvironmental healthGlioma Diagnosis and TreatmentFerroptosis and cancer prognosisCancer Immunotherapy and Biomarkers
Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy | Litcius